GOODWILL(SH:688246)2022-10-28 16:00Financial Performance - Revenue for Q3 2022 reached ¥203,403,680.64, an increase of 16.77% year-over-year, while year-to-date revenue was ¥455,321,747.12, up 18.50%[5] - Net profit attributable to shareholders for Q3 2022 was ¥27,290,030.20, a significant increase of 497.42% compared to the same period last year[5] - The net profit excluding non-recurring gains and losses for Q3 2022 was ¥26,480,915.84, up 482.19% year-over-year[5] - Basic and diluted earnings per share for Q3 2022 were both ¥0.20, a substantial increase of 348.07% compared to the same period last year[6] - The net profit for the third quarter of 2022 was a loss of ¥18,939,625.90, an improvement from a loss of ¥35,853,138.66 in the same quarter of 2021[24] - The total comprehensive income attributable to the parent company for Q3 2022 was 1,475,893.23 CNY, compared to a loss of 22,578,714.32 CNY in the same period last year[25] - The company reported a total comprehensive loss of -18,939,625.90 CNY for Q3 2022, compared to a loss of -35,853,138.66 CNY in the previous year[25] Research and Development - Research and development expenses totaled ¥45,293,137.80 for Q3 2022, representing 22.27% of revenue, an increase of 3.59 percentage points from the previous year[6] - The company plans to continue its focus on research and development, with increased investment in personnel and projects[12] - Research and development expenses increased significantly to ¥135,334,064.77 in the first three quarters of 2022, compared to ¥96,437,052.14 in 2021, marking an increase of 40.4%[23] - The company’s financial performance indicates a strategic focus on R&D and cost management, as evidenced by the increase in R&D expenses and the reduction in net losses compared to the previous year[24] Assets and Liabilities - The total assets at the end of Q3 2022 were ¥2,333,501,121.18, a decrease of 4.56% compared to the end of the previous year[6] - The company reported a total asset value of ¥2,333,501,121.18 as of the end of the third quarter of 2022, down from ¥2,444,869,042.34 at the end of the previous year[20] - Total liabilities decreased to ¥550,007,469.04 in the third quarter of 2022, compared to ¥650,266,679.24 in the same quarter of 2021[19] - The total equity attributable to shareholders of the parent company was ¥1,744,263,095.29, slightly up from ¥1,734,956,287.12 in the previous year[20] - The company recorded a significant increase in inventory, which rose to ¥500,029,818.48 from ¥400,778,242.85 year-over-year, indicating a growth of 24.8%[20] Cash Flow - The company reported a cash flow from operating activities of -¥288,844,282.25 for the year-to-date period[6] - The net cash flow from operating activities for the first three quarters of 2022 was -288,844,282.25 CNY, worsening from -209,569,438.54 CNY in the previous year[27] - Cash inflow from operating activities totaled 401,685,600.36 CNY, while cash outflow amounted to 690,529,882.61 CNY, resulting in a net cash outflow of 288,844,282.25 CNY[27] - The company reported cash and cash equivalents at the end of Q3 2022 of 555,579,181.95 CNY, down from 1,109,148,322.49 CNY at the beginning of the period[28] - Investment activities generated a net cash flow of -107,819,577.63 CNY, compared to -1,337,468.54 CNY in the same period last year[28] - The company raised 28,578,000.00 CNY from borrowings in Q3 2022, a significant decrease from 167,608,589.00 CNY in the previous year[28] - The total cash outflow from financing activities was 185,486,225.29 CNY, compared to 83,406,534.89 CNY in the same period last year[28] Shareholder Information - The total number of common shareholders at the end of the reporting period is 8,628[13] - The largest shareholder, Xia Jun, holds 24,690,198 shares, representing 17.91% of total shares[13] - The second-largest shareholder, Guoshou Chengda (Shanghai) Health Industry Equity Investment Center, holds 19,569,619 shares, accounting for 14.19%[13] - The top ten shareholders collectively hold a significant portion of the company's shares, with the top three alone accounting for over 42%[14] - The company has not disclosed any significant changes in shareholder relationships or actions among the top shareholders[15] Operational Insights - The report does not indicate any significant operational issues during the reporting period[16] - The company has not provided any future performance guidance or outlook in the current report[16] - There are no new product developments or market expansion strategies mentioned in the report[16]